CAIRO: The number of Egyptian registrants who used a new website to sign up for Egypt’s issue of hepatitis C treatment medication Solvadi had reached 175,252 just three days after the website went online Thursday, Youm7 reported Saturday.
According to the Ministry of Health, the Dakahlia governorate had the most registrants, followed by Sharqiah and Cairo. The Wadi Gedid governorate had the least number of registrants.
Solvadi, a drug from American drug company Gilead, is claimed to have over a 90 percent success rate in curing some strains of hepatitis c.
The Ministry of Health website lets patients book an examination date online instead of waiting in long queues at hospitals and medical centers to receive the drug.
Sovaldi is set to begin its Egyptian distribution in October, and Egypt is expected to receive 225,000 bottles at a reduced price. Egypt will have the ability to order more in coming years.
Hailed by many medical professionals, Sovaldi has been called a breakthrough for hepatitis C patients. “[Patients] used to depend on interferon injections that were not quite efficient for all patients,” Dr. Gamal Esmat, a member of Egypt’s Viral Hepatitis C Committee, told The Cairo Post Thursday.
Egypt has the highest rate of hepatitis C infection in the world according to the United Nations Population Fund, according to which 14.7 percent of the population between ages 15-49 have tested positive for the virus.
Additional Reporting by Dana el-Hadidi